Related by context. All words. (Click for frequent words.) 69 eTag assays 68 fusion enhancers 68 pharmacodynamic markers 68 HCV protease inhibitors 67 metabolomic profiling 67 pharmacodynamic parameters 67 biomarker identification 67 immune modulating 66 biologic pathways 66 genomic biomarkers 66 biomarker validation 66 metabonomics 66 histone deacetylase HDAC 66 Hedgehog inhibitor 65 molecular biomarkers 65 ALK inhibitors 65 Adnectin 65 therapeutic radiopharmaceuticals 65 pharmacogenetic tests 65 antitumor effect 65 serum biomarkers 65 preclinically 64 validate biomarkers 64 predictive toxicology 64 optical biosensors 64 rxRNA 64 sd rxRNA 64 TLR antagonists 64 OnDose TM 64 neuroprotective properties 64 LNP formulations 64 therapeutic monoclonal antibody 64 validating biomarkers 64 Onconase 64 anti angiogenic drugs 64 developmental neurotoxicity 64 endothelin antagonist 64 Mammostrat 64 kidney urologic 64 vivo potency 64 Anticalins ® 64 CCR3 64 therapeutically relevant 64 FGFs 64 Dyax phage display 64 Nanobodies ® 63 biomarker assays 63 humanized monoclonal antibodies 63 PDE# inhibitors 63 predictive biomarkers 63 CB2 receptor 63 diagnostic prognostic 63 ADME Tox 63 mTOR inhibitors 63 HERmark assay 63 phage display libraries 63 Darapladib 63 epigenetic therapies 63 targeted anticancer therapies 63 pharmacologic approaches 63 phenotyping 63 antitumoral 63 investigational therapies 63 pharmacodynamic effects 63 tubulin inhibitor 63 adrenergic regulation 63 Therapeutic antibodies 63 PI3K/mTOR 63 immunotoxins 63 favorable pharmacokinetic 63 Anticalins R 63 anticancer therapeutics 63 druggable targets 62 treating neuropathic pain 62 sirtuin enzymes 62 vivo pharmacology 62 THR beta agonist 62 BRAF inhibitors 62 chemopreventive agents 62 pharmacodynamic endpoints 62 stratifying patients 62 immunostimulatory effects 62 biologic therapeutics 62 Panzem 62 human microdosing 62 pharmacogenetic testing 62 antiplatelet therapies 62 microRNA biomarkers 62 DNA methyltransferases 62 oral taxane 62 immunotherapeutic approaches 62 ALV# 62 EGFR HER 62 prostanoid 62 therapeutic monoclonal antibodies 62 enzyme inhibitor 62 fatty acid biosynthesis 62 MEK inhibitors 62 HepDirect technology 62 Aganocide TM 62 biochemical profiling 62 Membrane proteins 62 intranasal delivery 62 carbohydrate polymers 62 Anticalins 62 molecular biomarker 62 toxicogenomics 62 genomic proteomic 62 vascular disrupting agents 62 Poly ICLC 62 selective kinase inhibitors 62 optimal dosing regimens 62 physico chemical properties 62 EGFR pathway 62 Spiegelmers 62 TOCOSOL Camptothecin 62 BRAF kinase 62 molecular determinants 62 CellPort Technologies 62 bone metabolism 62 Corus CAD 62 intestinal mucosal 62 tumor hypoxia 61 PROCHYMAL 61 individualize therapy 61 neuropsychiatric diseases 61 CoVal TM fusion 61 Smac mimetic 61 PLAC test 61 protein kinase inhibitors 61 Exelixis compounds 61 sirtuin activators 61 inhibit enzymes 61 SIRT1 activation 61 bioactivity 61 vitro ADME 61 splice variants 61 optimal dosing 61 PET tracers 61 biomolecular interactions 61 iPS derived 61 methylation biomarkers 61 KL4 surfactant 61 NuMimetic TM 61 therapeutically useful 61 metabolomic profiles 61 Src inhibitors 61 diagnostic biomarker 61 KineMarker TM 61 systemic RNAi 61 PGxPredict tests 61 Phylomer ® 61 PD2i ® algorithm 61 triterpenoids 61 A3 adenosine receptor 61 mGluR5 antagonist 61 Prodarsan ® 61 metabolite identification 61 OnDose 61 CellCiphr 61 microRNA profiling 61 cytoprotective 61 HCV replication 61 synthetic peptides 61 MMP inhibitors 61 NanoCrystal Technology 61 enzymatic pathways 61 mGlu2 3 61 teplizumab 61 cMET 61 integrative pharmacology 61 Flow cytometry 61 small molecule activators 61 neuronal nicotinic receptors NNRs 61 Fc receptor 61 ReCyte 61 antiangiogenic agents 61 immunomodulatory properties 61 toxicogenomic 61 HepDirect R 61 Vaxfectin TM 61 GPR# agonists 61 antitumour 61 mGluR5 antagonists 61 deacetylase inhibitors 61 Squalamine 61 genetic biomarkers 61 biologic pathway 61 PARP inhibition 61 pharmacokinetic parameters 61 Tß4 61 Aganocide ® 61 chemoprotective 61 Fibroblast Growth Factor Receptor 61 metabolomic 61 ENMD # 61 Novavax VLP vaccine 61 HuLuc# 61 diagnostic biomarkers 61 antisense inhibitors 61 trastuzumab DM1 61 anti androgens 61 biomarker assay 61 cytotoxics 61 multiplex assay 60 Trofex 60 cytochromes P# 60 dasatinib Sprycel 60 synthetic lethality 60 synthetic siRNA 60 biocatalytic processes 60 Cerashield 60 recombinant albumin 60 HepDirect prodrug 60 monoclonal antibody therapeutics 60 BrachySil TM 60 busulfan 60 blood coagulation disorders 60 Rigorous scientific 60 inhibit metastasis 60 recombinant antibodies 60 inhibit EGFR 60 proliferative disorders 60 p# activation 60 cardiotoxic 60 genomic biomarker 60 Foradil Aerolizer 60 isoform selective 60 RIGScan CR 60 SGS# 60 ADVEXIN therapy 60 oral talactoferrin 60 aerosolized AAT 60 phage display technology 60 hERG 60 ischemic tissues 60 siRNAs targeting 60 systemic immunosuppressive drugs 60 anticancer activity 60 JAK3 60 TGR5 60 antiangiogenic therapy 60 CINQUIL 60 HSP# inhibitors 60 protein tyrosine phosphatases 60 hypoxic tumors 60 immunosuppressive regimens 60 molecular abnormalities 60 novel peptides 60 convenient dosing regimens 60 Li Fraumeni 60 pharmacodynamic properties 60 chemosensitivity 60 HuMax TAC 60 γ secretase 60 effector functions 60 small molecule PEGylation 60 CBLC# 60 oral gallium 60 epigenetic therapeutics 60 antifibrotic 60 metabolite profiles 60 Immunosuppressive drugs 60 vaginal microbicides 60 novel antiviral therapeutics 60 lapatinib Tykerb 60 DXL# 60 OGG1 60 metabolite profiling 60 CINTREDEKIN BESUDOTOX 60 Personalized Immunotherapy 60 molecularly targeted 60 prognostic biomarkers 60 ESBA# 60 cardiac repolarization 60 therapeutic regimens 60 cyclophilin inhibitors 60 theranostic 60 Hair follicle 60 telomerase activator 60 anti angiogenic agents 60 CB1 antagonists 60 anti dyslipidemic 60 peptidomimetic 60 TPMT 60 Nanobody ® 60 topical formulations 60 biomarker discovery validation 60 glucagon receptor 60 novel radiopharmaceuticals 60 Nanobodies 60 histone deacetylase inhibitor 60 epigenomic 60 adeno associated viruses 60 antiresorptive 60 Genz # 60 rxRNA ™ compounds 60 triglyceride lowering 60 synthetic siRNAs 60 Tekmira SNALP technology 60 cardiotoxic effects 60 peptidic 60 sd rxRNA compounds 60 pharmacogenomic tests 60 TransVax tm 60 Isis antisense 60 cobiprostone 60 pharmacokinetic interactions 60 thalidomide Thalomid 60 effector function 60 preclinical efficacy 60 bioinformatic approaches 60 modifier genes 60 Nektar proprietary 60 NNR Therapeutics 60 inhibit angiogenesis 60 antibody mediated 59 Smac mimetics 59 immunoregulatory 59 GPCR targets 59 therapeutic peptide 59 Umbilical cord stem cells 59 Zysolin TM 59 AMPAKINE 59 multiplexed assays 59 miRNA biomarkers 59 biomarkers 59 methylation markers 59 antisense compounds 59 siRNA therapeutics 59 clevidipine 59 TLR agonists 59 E2F Decoy 59 bioactive molecules 59 miRview mets 59 ADME 59 P2V TM 59 postapproval 59 peptides proteins 59 staphylococcal vaccine 59 pharmacological chaperone 59 rolipram 59 Cerashield ™ 59 synthetic retinoid 59 putative biomarkers 59 JAK inhibitors 59 heparanase 59 acadesine 59 anti CD3 59 potency selectivity 59 hepatic fibrosis 59 tumorigenicity 59 Cardio Vascu Grow 59 p# inhibitor 59 Anticalin 59 lipid particle 59 RNA antagonists 59 MAXY VII 59 faropenem 59 antimitotic 59 recombinant plasma 59 molecularly targeted therapies 59 Myriad Flurizan 59 targeting PCSK9 59 DNA methylation patterns 59 pharmacotherapeutic 59 acetylcholinesterase AChE 59 rifalazil 59 bioactive components 59 Zemplar Capsules 59 cyclic AMP cAMP 59 ghrelin antagonist 59 Stapled Peptide 59 protein homeostasis 59 cartilage regeneration 59 botanically derived 59 Lisofylline 59 synovial cells 59 NPM1 mutation 59 siRNA knockdown 59 PIK3CA 59 Lisofylline LSF 59 Archexin 59 edifoligide E2F Decoy 59 NEUGENE R 59 radionuclide therapy 59 RNAi compounds 59 biostatistical analysis 59 flavopiridol 59 CYT# potent vascular disrupting 59 epothilones 59 demonstrated anti amnesic 59 prognostic markers 59 telomerase activation 59 JAK3 inhibitor 59 JAK#/JAK# 59 BioSilicon 59 anti resorptive 59 oral antiviral 59 Human cl 59 GIPET 59 hypericin 59 MetAP2 59 potent cytotoxic 59 HQK 59 immune suppressive 59 antimetabolites 59 Valproic acid 59 p# inhibitors 59 hepatotoxic 59 IMiDs 59 transgenic rats 59 pro angiogenic 59 polyketides 59 physicochemical properties 59 TRIST study 59 NV1FGF 59 Treg cell 59 #T# L1 59 anticancer therapies 59 therapeutics diagnostics 59 ganaxolone 59 Theranostics 59 cellular immunotherapy 59 mitochondrial toxicity 59 inhibiting mTOR 59 NEUGENE antisense 59 JAK inhibitor 59 oral prodrug 59 undifferentiated stem cells 59 Biomerk Tumorgrafts 59 hedgehog pathway 59 glycomics 59 phenotypic expression 59 Ontak 59 mTOR kinase 59 microtubule inhibitor 59 radiosensitivity 59 Davanat 59 amyloid formation 59 Vorinostat 59 N glycan 59 novel peptide 59 immunological responses 59 ACAT2 59 mutated K ras 59 cathepsin K 59 anti secretory 59 Lipoic acid 59 fumagillin nanoparticles 59 Protein Kinase C 59 delafloxacin 59 Spiegelmer ® 59 ZFP TF 59 rBChE 59 HCV antiviral 59 mda 7 59 cellular pathways 59 sulfonylhydrazine class 59 non nucleoside 59 gefitinib Iressa 59 MyVax ® 59 granzyme B 59 Deforolimus 59 genotype phenotype 59 cannabinor 59 Xencor XmAb 59 ZOLINZA 59 mechanistic insights 59 Locked Nucleic Acid LNA 59 polymorphs 59 pharmacokinetics pharmacodynamics 59 tumor subtypes 59 prostone 59 immunoregulation 59 novel anticancer 59 biotransformation 59 DepoVax TM 59 posttranslational modifications 59 pharmacodynamic PD 59 identify protein biomarkers 59 viral inactivation 59 TLK# 59 cytotoxicity assays 59 p# biomarker 59 siRNA therapeutic 59 antiplatelet medications 59 RNAi therapeutic platform 59 GSK# [002] 58 nutrient supplementation 58 pleiotropic effects 58 Pertuzumab 58 nonhuman primate model 58 trastuzumab DM1 T DM1 58 antiangiogenesis 58 topical microbicides 58 thymidylate synthase TS 58 post surgical adhesions 58 enzastaurin 58 Arranon 58 lung cancer chemoprevention 58 Multiple logistic regression 58 synthetic biomaterials 58 protein microarrays 58 PROGENSA PCA3 assay 58 HuCNS SC ® 58 gene expression microarrays 58 neurotrophic 58 Anticalin ® 58 mechanistic studies 58 superparamagnetic iron oxide nanoparticles 58 neuro protective 58 HIF PH inhibitors 58 Posiphen TM 58 Azedra 58 mertansine 58 Bioaccelerate compounds under 58 receptor inhibitor 58 norepinephrine reuptake inhibition 58 IL# PE#QQR 58 galectin 58 ATL# [002] 58 immuno inflammatory 58 OxBC 58 immuno suppressive 58 XmAb 58 BioMAP 58 SERMs 58 anti tumoral 58 FTIs 58 non nucleoside HCV 58 fibrotic disease 58 gamma secretase inhibitor 58 discodermolide 58 idiotype vaccine 58 murine models 58 p#/CBP 58 hPTH #-# 58 telomerase inhibition 58 nanoparticle formulations 58 antiapoptotic 58 Cardiotoxicity 58 hematopoietic malignancies 58 histone deacetylases 58 bone morphogenetic proteins 58 mecamylamine 58 Aganocide 58 radiolabeled TM# 58 inhibiting tumor 58 transfection efficiency 58 CMV vaccine 58 VDAs 58 antiproliferative effects 58 antibody reagents 58 CCR1 58 AAG geldanamycin analog 58 cytolytic 58 Psoraxine R 58 galiximab 58 immune modulatory 58 CB2 selective 58 adipiplon 58 containing abacavir 58 antigenicity 58 ImmuneY2 58 bioseparation 58 cancer chemoprevention 58 anticoagulant reversing agent 58 combinatorial libraries 58 PEGPH# 58 drugable 58 EHT AGN 58 personalized immunotherapy 58 IVIVC 58 Phage Pharmaceuticals 58 VeraTag 58 PDE inhibitors 58 TNF alpha antagonist 58 Zavesca r 58 Vaxfectin 58 novel anti infective 58 RIP1 kinase 58 AdhTAP 58 Inflammatory diseases 58 Lpathomab 58 TOCOSOL 58 anti CD# antibodies 58 incyclinide 58 neurite outgrowth 58 Preclinical studies suggest 58 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 58 metaglidasen 58 monoclonal antibodies mAbs 58 antiangiogenic 58 Nanobodies R 58 Prodarsan R 58 uricase 58 K ras mutations 58 insulin analogs 58 riociguat 58 monoclonals 58 differential gene expression 58 Affinitak 58 phosphorylated proteins 58 encapsulates siRNAs 58 nutrigenomic 58 PORxin TM platforms 58 inhibiting enzymes 58 erlotinib Tarceva 58 inhibit platelet function 58 anti amnesic 58 peptide mimetics 58 comparative genomic 58 torsemide ER 58 hematologic oncology 58 RNAi therapeutic targeting PCSK9 58 cardiometabolic disorders 58 hESC derived cardiomyocytes 58 protein biosynthesis 58 MGMT methylation 58 NMDA antagonists 58 Lixivaptan 58 ticagrelor Brilinta 58 Notch inhibitor 58 pharmacogenetic 58 IoGen ™ 58 gamete formation 58 Th2 cytokines 58 gastrointestinal absorption 58 nalbuphine ER 58 small molecule agonists 58 AMPK activators 58 TLR9 agonists 58 tamoxifen metabolism 58 insulin analogues 58 DGAT 58 VeriStrat 58 humoral responses 58 favorable pharmacokinetic profile 58 pharmacokinetic PK profile 58 potent suppressor 58 PORxin TM 58 OMP #M# 58 biomarkers predictive 58 SNALP technology 58 prognostic indicators 58 IMiDs ® 58 Streptomyces bacteria 58 renin inhibition 58 Amplimexon 58 tranilast 58 antiviral antibacterial 58 radezolid 58 PDE4 inhibitors 58 Pancreate 58 insertional mutagenesis 58 NeoLipid TM 58 intracellular signaling pathways 58 enzyme immunoassay EIA 58 Diep Tran MD 58 teratogenicity 58 mTOR signaling pathway 58 Pyridorin 58 plasma pharmacokinetics 58 HIV tropism 58 cognitive enhancer 58 Discovery Labs KL4 58 immunotoxin 58 Immunotherapeutic 58 endothelin antagonists 58 proteins peptides 58 Genedata Expressionist ® 58 cediranib 58 biothreat agents 58 immune modulator 58 NovaBay Aganocide compounds 58 midstage clinical 58 PROfusion 58 genetic determinants 58 pharmacogenomic 58 nonclinical studies 58 indibulin 58 Genetic variations 58 Fleximer R 58 aerosolized surfactant 58 Xenopus embryos 58 opioid tolerance 58 neuronal signaling 58 TPI ASM8 58 immunosuppressant therapies 58 genomic profiling 58 DAVANAT 58 MTT assay 58 resolvins 58 2 methoxyestradiol #ME# 58 nanopolymer 58 induced anemia 58 INS# [001] 58 underlying molecular mechanisms 58 RNAi therapeutic targeting 58 IDO inhibitor 58 Triapine R 58 antagomirs 58 stem cell pluripotency 58 Factor Xa inhibitors 58 AlloMap testing 58 neratinib 58 liposomal formulations 58 ErbB3 HER3 58 environmental toxicants 58 glyco 58 polyketide 58 Actimmune ® 58 CCX# 58 MediGene focuses 58 neurotrophic factors 58 OHR/AVR# 58 VIBEX MTX 58 bryostatin 58 potent inhibitors 58 MediVas 58 chemoresistant 58 p# pathway 58 abiotic stress tolerance 58 Activity Assay 58 Corgentin 58 multi factorial diseases 58 bioactive compound 58 vitro dissolution 58 serotonin synthesis 58 gepirone ER 58 immunomodulating agents 58 SILENOR 58 antisense therapeutics 58 nasally delivered 58 peptide antigens 58 Posiphen 58 targeted radiotherapeutic 58 carbohydrate compounds 58 periodontal tissues 58 bone grafting procedures 58 lipid nanoparticle LNP 58 biotherapies 57 NEUGENE 57 p# Shc 57 Hemopurifier ® 57 circulating endothelial cells 57 multitargeted 57 PV module efficiencies 57 SGLT 2 57 DNA methylation biomarkers 57 Symadex 57 cathepsins 57 bioactives 57 EC Cysteamine 57 neuroactive 57 vitamin D analogs 57 #ME# 57 hawthorn extract 57 amyloid plaque formation 57 bronchopulmonary dysplasia BPD 57 mTOR inhibition 57 pharmacophore 57 NMR LipoProfile test 57 Zemiva TM 57 protein ligand 57 efficacious therapies 57 vidofludimus 57 RG# synthetic human 57 EP #R 57 Protease inhibitors 57 AEG# 57 VKORC1 57 Smac mimic 57 qNPA 57 Spiriva HandiHaler 57 tolerability pharmacokinetics 57 molecular underpinnings 57 Factor VIIa 57 lipid lowering therapies 57 DPX Survivac 57 r hGH 57 MyVax personalized immunotherapy 57 inhibit viral replication 57 non pharmacological interventions 57 HepaMate 57 DepoVax 57 oral mTOR inhibitor 57 MCSP respectively 57 adenoviral vectors 57 Akt activation 57 GRNOPC1 contains 57 mesenchymal cell 57 Soy isoflavones 57 NF kB signaling 57 VeraTag assays 57 molecule therapeutics 57 biologic plausibility 57 alpha fetoprotein AFP 57 lymphoid tumors 57 thymidylate synthase 57 Trastuzumab DM1 57 pregabalin Lyrica 57 immunomodulation 57 humanised monoclonal antibody 57 colorectal tumor 57 PhenoSense GT 57 Vidofludimus 57 S. maltophilia 57 Vaxfectin R 57 Xcytrin R 57 Gamunex C 57 XmAb# 57 urothelial cancer 57 deforolimus 57 Interferon alpha 57 IgG1 antibodies 57 ALN RSV program 57 therapeutic modality 57 BHT DNA 57 PPARγ 57 dissolving microneedles 57 multicenter clinical trials 57 rEEG 57 NanoCrystal technology 57 oral picoplatin 57 genotypic resistance 57 CVT E# 57 GelSite polymer 57 Tasimelteon 57 miR #a [002] 57 M# rationally 57 FUS protein 57 immuno modulatory 57 treat chronic sinusitis 57 immunomodulators 57 candidate TNFerade biologic 57 suppress viral replication 57 SGLT2 inhibitors 57 lymphomas leukemias 57 thromboembolic disease 57 engineered RAP peptides 57 endogenous ligands 57 breast cancer subtypes 57 anionic backbone 57 immune globulins 57 Rigel R# 57 Multiple Proteases And 57 antiandrogens 57 JAK2 inhibitor 57 epigenetic regulation 57 Anticalin R 57 commercialize ZYFLO CR 57 fluorescent quantum dots 57 miRNA therapeutics 57 intensive lipid lowering 57 oral PTH 57 ERK signaling 57 please visit www.metabolon.com 57 sargramostim 57 LNA TM 57 #ß HSD1 57 p# biomarkers 57 DNA gyrase 57 gene loci 57 osteopontin OPN 57 epithelial tissues 57 menadione 57 RRM1 57 antiarrhythmic 57 HepDirect 57 intradermal delivery 57 intracellular pathways 57 Thalomid ® 57 Biochronomer 57 hypoxia selective 57 resorptive 57 chimeric antibody 57 rhThrombin 57 HDAC inhibition 57 XP #L 57 successfully commercialize Iluvien 57 LEP ETU 57 preclinical pharmacokinetic 57 pharmacological therapies 57 viral kinetics 57 aptamer therapeutics 57 anti infective therapies 57 empiric therapy 57 intracellular uptake 57 telomerase inhibitor 57 antihormonal 57 selective inhibition 57 therapeutic mAbs 57 proton MR spectroscopy 57 KRAS mutation 57 EndoTAG TM 57 systemic antifungal 57 transcutaneous immunization TCI 57 preclinical pharmacology 57 Lipocine 57 ADMETRx 57 commercialize deforolimus 57 TRIM5a 57 oral antiplatelet agent 57 Anavex #-# 57 Bioral 57 excretion ADME 57 DPP4 57 antiangiogenic drugs 57 rhLF 57 CardioPET 57 safer smallpox vaccines 57 SERCA2a 57 Angiocept 57 CDK inhibitors 57 intercellular signaling 57 CCR9 antagonist 57 binding affinities 57 relapsed ALL 57 microarray gene expression 57 ARIKACE ™ 57 statins cholesterol lowering 57 STAT3 signaling 57 Chemophase 57 lipidoid 57 physiologic mechanisms 57 Nanobodies TM 57 Afatinib 57 Spiegelmer 57 act synergistically 57 selective agonists 57 CyPath ® 57 MET amplification 57 neovascular diseases 57 benzimidazole 57 MyVax 57 orBec 57 Xanafide 57 clinically differentiated 57 xenobiotic 57 stimulate insulin secretion 57 pharmacologically relevant 57 immunology oncology 57 pharmacokinetic properties 57 R#/MEM # 57 BNC# 57 Atrasentan 57 DGAT1 57 anti thrombotics 57 GnRH antagonists 57 novel immunotherapies 57 monoclonal antibody therapies 57 insulin sensitizing 57 tolevamer 57 antiangiogenic agent 57 BEXXAR Therapeutic Regimen 57 VEGF receptor 57 immunostimulants 57 gp# vaccine 57 TÎ ² 4 57 CORT # 57 monoclonal anti 57 Initiate Clinical Trial 57 mimetic compounds 57 GAP #B# 57 extracellular proteins 57 Dr. Sosne 57 Virulizin ® 57 Beta catenin pathway 57 alemtuzumab MS 57 Tasigna prolongs 57 cancer immunotherapies 57 siRNA compounds 57 hippocampal neurogenesis 57 bezafibrate 57 CobaCyte 57 osteocalcin protein 57 quantitative proteomics 57 ddRNAi 57 recombinant enzyme 57 dermaceutical 57 proteasome inhibitors 57 TAT Bim 57 atrasentan 57 pain palliation 57 ONCONASE R 57 lentiviral vectors 57 cytotoxic therapies 57 hES cells 57 Arabidopsis genes 57 Dr. LaMattina 57 Generx TM 57 coactivators 57 antibiofilm 57 TriGrid 57 experimentally validated 57 neurotransmitter receptor 57 QVAR